|Document ID (ISN)||110428|
|Convention or series no.
||Risher J.F., Keith L.S.
Inter-Organization Programme for the Sound Management of Chemicals (IOMC)
||Iodine and inorganic iodides: Human health aspects
||World Health Organization, Distribution and Sales Service, 1211 Genève 27, Switzerland, 2009. iv, 53p. Approx. 320 ref.
||http://www.who.int/entity/ipcs/publications/cicad/cicad72.pdf [in English]
||Conclusions of this criteria document on iodine and inorganic iodides: inhalation exposure to low iodine vapour concentrations have been shown to result in increases in airway resistance and a decrease in breathing rate in guinea pigs. The primary effects of long-term oral exposure to elevated amounts of inorganic iodide are, paradoxically, hyperthyroidism or hypothyroidism, due to the complex physiological processes involved in regulating thyroid activity to maintain iodine homeostasis. Iodine does not cause mutagenic effects. The radioactive iodine isotopes are outside the scope of this document. Detailed summaries in French and Spanish.
||iodine and compounds; iodides; health hazards; toxicology; IPCS
||literature survey; iodine; hydriodic acid; ILO; criteria document; WHO; hydrocyanic acid; thyroid disorders; animal experiments; UNEP
||B - Chemical safety information sheets
|Country / State or Province||WHO|
||Toxic and dangerous substances
|Broad subject area(s)
||Halogens and their inorganic compounds